Back to Search Start Over

Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial

Authors :
Paul Frappé
Isabelle Quéré
Marc Philip Righini
Susan R. Kahn
Helia Robert-Ebadi
Frédéric Glauser
Grégoire Le Gal
Jean-Marc Diamand
Anne Tissot
Marc Blondon
Jean-Philippe Galanaud
Pierre Ouvry
Service d'angiologie et d'hémostase (MR)
Hôpital Universitaire de Genève
Service de médecine interne générale (SMIG)
Groupe de recherche sur la thrombose (GRT (EA 3065))
Université Jean Monnet [Saint-Étienne] (UJM)
Service de Médecine Interne B
Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)
Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO)
Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM)
Université de Brest (UBO)-Université de Brest (UBO)
CIC Brest
Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital de la Cavale Blanche
Institut Brestois Santé Agro Matière (IBSAM)
Université de Brest (UBO)-Université de Brest (UBO)-Université de Brest (UBO)
Source :
Journal of Thrombosis and Haemostasis, Vol. 17, No 3 (2019) pp. 507-510, Journal of Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis, Wiley, 2019, 17 (3), pp.507-510. ⟨10.1111/jth.14387⟩
Publication Year :
2019

Abstract

Essentials Management of patients with calf deep vein thrombosis remains controversial. We conducted a post-hoc analysis of a placebo controlled LMWH randomized clinical trial. Pain was assessed using visual analogue scale at inclusion, one and six weeks. There was no difference in pain control between the two arms. SUMMARY: Background The optimal management of distal deep vein thrombosis (DVT) is highly debated. The only available placebo-controlled trial suggested the absence of clear benefit of anticoagulation. Many physicians feel that, beyond preventing thromboembolic complications, anticoagulation with low-molecular-weight heparin (LMWH) has the potential to improve pain control. Objectives To analyze whether LMWHs decrease pain in patients with distal deep vein thrombosis. Patients and methods Two-hundred and fifty-two patients included in a multicenter, placebo-controlled, randomized clinical trial of LMWH in patients with acute distal DVT and who were asked to rate their pain at inclusion and at each medical visit, using a visual analogue pain scale (VAS). Results One hundred and thirty patients were randomized in the therapeutic nadroparin arm and 122 patients were randomized in the placebo arm. Mean VAS values were 4.6 (standard deviation [SD] 2.5) at inclusion, 2.1 (SD 2.0) at 1 week and 0.4 (SD 1.2) at 6 weeks. We calculated the individual variation in VAS between inclusion and 1 week in patients in whom VAS was available at the two study time-points. There was no difference in the mean VAS reduction between patients treated with therapeutic nadroparin (n = 106) and with placebo (n = 109): -2.6 (SD 2.4) vs. -2.3 (SD 2.0) after 1 week and -4.4 (SD 2.8) vs. -4.0 (SD 2.4) after 6 weeks, respectively. The use of compression stockings was associated with a reduction in pain. Conclusion These data suggests that LMWH use does not improve pain control as compared with placebo in patients with acute distal DVT.

Details

Language :
English
ISSN :
15387836 and 15387933
Database :
OpenAIRE
Journal :
Journal of Thrombosis and Haemostasis, Vol. 17, No 3 (2019) pp. 507-510, Journal of Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis, Wiley, 2019, 17 (3), pp.507-510. ⟨10.1111/jth.14387⟩
Accession number :
edsair.doi.dedup.....ecc874e072a20ef091ac8640b2abf274
Full Text :
https://doi.org/10.1111/jth.14387⟩